Acadia Healthcare vs LifeStance Health
ACHC and LFST side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACHC and LFST compare
LifeStance Health is the larger company, worth 1.5 times as much as Acadia Healthcare ($5.4B against $3.5B).
LifeStance Health grew revenue faster over the last twelve months (22.6% versus 4.5% for Acadia Healthcare).
LifeStance Health keeps more of each dollar of sales as profit, with a net margin of 4.3% compared with −33.1% at Acadia Healthcare.
LifeStance Health scores higher on the StockData Score (12 against 7 for Acadia Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACHC | LFST |
|---|---|---|
| Size and price | ||
| Market cap | $3.5B | $5.4B |
| Share price | $37.78 | $14.08 |
| Change, 1 year | 117% | 119% |
| Change, 5 years | −39.0% | 62.8% |
| Beta (5Y) | 0.60 | 1.17 |
| Employees | 25K | 11K |
| StockData Score | ||
| Total score | 7 | 12 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 74.1× |
| P/S | 1.0× (better) | 3.2× |
| P/B | 1.7× (better) | 3.6× |
| EV/EBITDA | – | 36.7× |
| P/FCF | – | 30.0× |
| FCF yield | −0.68% | 3.3% (better) |
| Fair value | $69.55 | $5.88 |
| Margin of safety | 45.7% (better) | −139% |
| Growth | ||
| Revenue growth (TTM) | 4.5% | 22.6% (better) |
| Revenue growth, 5Y average | 9.7% | – |
| Net income growth (TTM) | −1151% | – |
| EPS growth (TTM) | −1183% | – |
| Profitability | ||
| Operating margin | – | 6.2% |
| Net margin | −33.1% | 4.3% (better) |
| FCF margin | −0.70% | 10.7% (better) |
| Return on equity | −43.9% | 4.8% (better) |
| Return on invested capital | – | 5.4% |
| Financial health | ||
| Debt / equity | 1.16 | 0.18 (better) |
| Net debt / EBITDA | – | 0.35 |
| Interest coverage | – | 10.6× |
| Current ratio | 1.60 (better) | 1.44 |
| Altman Z-score | 1.14 | 5.16 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 145% | 98.7% |
| Held by insiders | 1.9% | 64.6% |
| Insider net buying, 12 months | – | −$849M |
| Short interest, % of float | 20.8% | 10.1% |
Go deeper
- ACHC stock overview
- ACHC income statement
- ACHC valuation and score
- LFST stock overview
- LFST income statement
- LFST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.